Plasma biomarker ORAI1 as a dual prognostic value for survival and postoperative quality of life in glioma patients

Zeyu Zhang, Yu Xiang, Ying Zhang, Hui Li, Yun Cheng · 2025

Read Plasma biomarker ORAI1 as a dual prognostic value for survival and postoperative quality of life in glioma patients by Zeyu Zhang, Yu Xiang, Ying Zhang, Hui Li, Yun Cheng (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12859135.txt.

Description

Zeyu Zhang and co-authors present a 2025 study on a blood marker for glioma, a common and deadly brain tumor. Doctors lack a simple blood test that predicts both survival and life quality after surgery. The team studied a protein called ORAI1, which controls calcium entry into cells.

They drew on two large tumor databases, with 309 and 563 patients, plus blood samples from fifty patients at their own center. High levels of the protein marked patients with more advanced tumors and shorter survival. Those patients also reported more pain and worse sleep in the first days after surgery. The marker thus links tumor biology to daily well-being, and it can be measured from a blood draw.

Catalog record

CREATORZeyu Zhang, Yu Xiang, Ying Zhang, Hui Li, Yun Cheng
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12859135

Browse the full library · About the Tower of Babel